GI
TVTX icon

GAMMA Investing’s Travere Therapeutics TVTX Stock Holding History

GAMMA Investing’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.4K Buy
606
+211
+53% +$9.36K ﹤0.01% 2544
2026
Q1 		$11.7K Sell
395
-115
-23% -$3.44K ﹤0.01% 2987
2025
Q4 		$19.5K Buy
510
+248
+95% +$8.06K ﹤0.01% 2632
2025
Q3 		$6.26K Sell
262
-182
-41% -$3.42K ﹤0.01% 3088
2025
Q2 		$6.57K Sell
444
-142
-24% -$2.35K ﹤0.01% 3012
2025
Q1 		$10.5K Buy
586
+383
+189% +$7.77K ﹤0.01% 2723
2024
Q4 		$3.54K Buy
203
+76
+60% +$1.34K ﹤0.01% 3048
2024
Q3 		$1.78K Buy
127
+38
+43% +$396 ﹤0.01% 3109
2024
Q2 		$732 Buy
89
+59
+197% +$397 ﹤0.01% 3133
2024
Q1 		$231 Buy
+30
New +$253 ﹤0.01% 3214

Other funds holding TVTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
HCMT
Highland Capital Management (Tennessee) Memphis, Tennessee $2.17B AUM 54.74% 1-Year Est. Return

GAMMA Investing's TVTX Position: Q2 2026 in Review

GAMMA Investing increased its Travere Therapeutics (TVTX) stake by 53% in Q2 2026, buying an estimated $9.36K and bringing the position to 606 shares worth $34.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2544.

GAMMA Investing first reported a position in TVTX in Q1 2024 and has held it in 10 quarters since. 35 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • GAMMA Investing held 606 shares of Travere Therapeutics worth $34.4K as of Q2 2026.
  • GAMMA Investing bought 211 Travere Therapeutics shares in Q2 2026, an estimated $9.36K.
  • Travere Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2544 holding.
  • GAMMA Investing first reported a position in Travere Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 35 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.